PureTech News

Sign up for
email alerts

To receive news as it is released, please sign up.

Press releases
Press Releases - 2021-12-01
Gelesis
PureTech Founded Entity Gelesis Announces FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition Officer
Press Releases - 2021-11-18
Gelesis
PureTech Founded Entity Gelesis Receives $30 Million Plenity® Order from Ro
Press Releases - 2021-11-16
Wholly Owned Pipeline
PureTech Announces Publication of Phase 1 Results for LYT-100 in the Journal Clinical Pharmacology in Drug Development and Provides Timing Updates
Press Releases - 2021-11-15
Other
PureTech Announces Participation in Two Upcoming Investor Conferences
Press Releases - 2021-11-12
Wholly Owned Pipeline
PureTech Presents Clinical Trial Design Supporting Wholly Owned Immuno-Oncology Candidate LYT-200 at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Press Releases - 2021-11-11
Wholly Owned Pipeline
PureTech Receives Orphan Drug Designation for Wholly Owned Candidate LYT-200 for the Treatment of Pancreatic Cancer
Press Releases - 2021-11-10
Other
Karuna
PureTech Receives Approximately $100 Million from Sale of a Portion of Founded Entity Shares
Press Releases - 2021-11-09
Karuna
PureTech Founded Entity Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China
Press Releases - 2021-11-09
Other
PureTech Announces Participation at the Jefferies London Healthcare Conference
Press Releases - 2021-11-01
Gelesis
PureTech is Pleased to Note Publication in Nature’s Scientific Reports Featuring the Gelesis Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage
Displaying 1 - 10 of 265

@PureTechH